Alivira

Visakhapatnam, India Founded: 2013 • Age: 13 yrs
Veterinary Products - Formulations APIs - Manufacturer Supplier

About Alivira

Alivira is a Healthcare company based in Visakhapatnam (India) founded in 2013. Veterinary Products - Formulations APIs - Manufacturer Supplier. It operates on a Veterinary Health Products and Veterinary Medical Retailers and Distributors model. Alivira has raised $20 million across 1 funding round from investors including Ascent Capital. The company has 528 employees. Alivira has completed 3 acquisitions, including Bremer Pharma, Provet Veteriner Products and Topkim. Its Indian entity Alivira Animal Health Limited reported revenue of β‚Ή393 Cr. Alivira offers products and services including Alivira Platform. Its focus areas include Veterinary Health Products.

Company details

Alivira offers Alivira Platform while focusing on providing healthcare solutions, veterinary medical retail and distribution, veterinary medical retail and distribution, and providing healthcare solutions. Veterinary Products - Formulations APIs - Manufacturer Supplier. Delivering reliable solutions, it emphasizes quality, efficiency, and meeting diverse client needs.

Key Metrics
  • Annual Revenue
    ₹393 Cr

    FY 2025 · -1% YoY

  • Net Loss
    -₹51.75 Cr

    FY 2025 · -14% margin

  • EBITDA
    ₹18.73 Cr

    FY 2025 · 5% margin

  • Total Equity Funding
    $20M (USD)

    in 1 rounds

  • Latest Funding Round
    $20M (USD), Series B

    Apr 2014

  • Investors
  • Employee Count
    528
  • Investments & Acquisitions

Products & Services of Alivira

Alivira offers a comprehensive portfolio of products and services, including Alivira Platform.

Alivira Platform
Healthcare

Veterinary Products - Formulations & APIs - Manufacturer & Supplier

Funding Insights of Alivira

Alivira has successfully raised a total of $20M through 1 strategic funding round. The most recent funding activity was a Series B round of $20 million completed in April 2014. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding $20M
  • Total Rounds 1
  • Last Round Series B β€” $20M
  • First Round $20M

    (Apr 2014)

  • Investors Count 1

All 1 funding rounds of Alivira with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
Apr 2014$20MSeries B––
Valuation history

1 investors in total: 1 institutional.

Investors in Alivira

Alivira has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include Ascent Capital.

All
Venture Fund
InvestorDescriptionFounded YearDomainLocation
AscentCapital is engaged in potato farming, grain marketing, and equipment services in Maine.
2000ascentcapital.inBengaluru, India
Premium access

Investor details for Alivira

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

Board of directors of Alivira Animal Health Limited (Alivira)

Alivira Animal Health Limited is the primary company behind Alivira. The board of Alivira Animal Health Limited currently have 5 directors; the longest-serving is Kamal Kishore Sharma, appointed in 2020. 29 earlier directors have ceased.

DirectorDesignationAppointedTenureEntity
Kamal Kishore Sharma
DIN 00209430
Director09 Sep 20206 yrs 2 moAlivira Animal Health Limited
Vijayalakshmi
DIN 09228935
Director15 Dec 20214 yrs 11 moAlivira Animal Health Limited
Rajaram Narayanan
DIN 02977405
Managing Director11 Apr 20224 yrs 7 moAlivira Animal Health Limited
Saurav Bhala
DIN 10490964
CFO06 Nov 20233 yrsAlivira Animal Health Limited
Srinivas Vasireddy
DIN 09771153
Additional Director01 Oct 20251 yr 1 moAlivira Animal Health Limited

People of Alivira

20 people are tracked at Alivira (10 in leadership, 10 in team); the tracked headcount is 528.

NameRoleGroup
Managing DirectorLeadership
Managing DirectorLeadership
Managing DirectorLeadership
Alan Kelly
Vice President BusinessLeadership
D K Singh
CEOLeadership
Batuhan Kavak
Production ChiefLeadership
Dr. K Venkata Narasimha Rao M.sc.
General Manager -head R&dLeadership
Mohan Murthy
Head Of ComplianceLeadership
Yawar Abbas
Business Head - Emerging MarketsLeadership
Edwin Vanhees Dvm
General Manager BeneluxLeadership
Kutay Murat Eğilmez
Sales RepresentativeTeam
Krishan Gupta
Sales ManagerTeam
Sreekanthreddy Nareddy
Regional Business ManagerTeam
Deepak Kale
Regional Business ManagerTeam
Drx Prashant Mishra
Sales ExecutiveTeam
Santosh Katkar
Manager - Distribution & LogisticsTeam
Sameer Pande
Sales ManagerTeam
Dharmjeet Kumar
Business ManagerTeam
Prabhu Kumar
Human Resources ExecutiveTeam
Anupam Jana
Zonal ManagerTeam
Premium access

Complete people profiles for Alivira

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

Financials of Alivira

Figures of Alivira Animal Health Limited, the primary company behind Alivira, for FY 2025. Revenue was ₹393 Cr (-1% year on year). Net loss was -₹51.75 Cr (-14% margin). EBITDA was ₹18.73 Cr (5% margin). Revenue has grown at a compounded annual rate of -7% over three years and -1% over five years.

  • ₹393 CrRevenue · FY 2025 · -1% YoY
  • -₹51.75 CrNet loss · -14% margin
  • ₹18.73 CrEBITDA · 5% margin
  • ₹47.78 CrPaid-up capital
  • 850Employees (provident fund records)
  • -7%Revenue CAGR, 3 years
  • -1%Revenue CAGR, 5 years

Balance sheet, profit and loss, cash flow and ratios of Alivira Animal Health Limited are on its company page.

Premium access

Detailed financial statements for Alivira

Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.

  • Statement rows
  • Financial ratios
  • Five-year trends
  • Downloads

Verified entity values are shown only after access is granted.

Investments & Acquisitions by Alivira

Alivira has strategically engaged in corporate development activities, having acquired 3 companies. Notable acquisitions include Bremer Pharma, Provet Veteriner Products and Topkim.

Acquisitions
Company NameDescriptionDomainLocationFoundedAcquiredAmount
Veterinary healthcare products are manufactured for animal care in Turkey.
provet.com.trKartal, Turkey1997Sep 2020β€’β€’β€’β€’
Veterinary health products are supplied for animal care needs.
bremer-pharma.deWarburg, Germany1982Apr 2018$2.8M
Animal feeds are produced by Topkim in Turkey since 1964.
topkim.com.trKartal, Turkey1964Nov 2015$7M
Premium access

Complete acquisition details for Alivira

Acquired stakes, deal sources and the complete acquisition history require an active premium plan.

  • Acquired stakes
  • Deal sources
  • Complete history
  • Exports

Verified entity values are shown only after access is granted.

Timeline of Alivira

5 dated milestones of Alivira across 7 years, from founding to its latest funding, stage changes and deals.

  1. Founded Alivira is founded.
  2. Funding First funding round of $20.0M.
  3. Acquisition Acquires Topkim.
  4. Acquisition Acquires Bremer Pharma.
  5. Acquisition Acquires Provet Veteriner Products.

Top companies in Pharmacy & Healthcare Retail Systems

2 companies that operate in the same segment as Alivira (Pharmacy & Healthcare Retail Systems) in India, ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
Offers a B2B managed marketplace for pharmacies
2019Bengaluru, Karnataka, IndiaUSD 20.02 MUSD 20.23 M218
Digital healthcare tools are offered for pharmacies and clinics management.
2012Mumbai, Maharashtra, IndiaUSD 1.19 BUSD 719.01 M215
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Related news about Alivira

Premium access

Complete news archive for Alivira

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Alivira

Alivira was founded in 2013 and raised its 1st funding round 1 year after it was founded.

Alivira is headquartered in Visakhapatnam, India. It is registered at Visakhapatnam, Andhra Pradesh, India.

Alivira is a funded company, having raised a total of $20M across 1 funding round to date. The company's 1st funding round was a Series B of $20M, raised on Apr 2014.

Alivira has 528 employees.

The primary company behind Alivira, Alivira Animal Health Limited, reported revenue of β‚Ή393 Cr for FY 2025, down 1% year on year.

Alivira offers Alivira Platform while focusing on providing healthcare solutions, veterinary medical retail and distribution, veterinary medical retail and distribution, and providing healthcare solutions. Veterinary Products - Formulations APIs - Manufacturer Supplier. Delivering reliable solutions, it emphasizes quality, efficiency, and meeting diverse client needs.

Alivira offers Alivira Platform.

Alivira has made 3 acquisitions, including Bremer Pharma, Provet Veteriner Products, and Topkim.

Alivira has 1 investor. Key investors include Ascent Capital.

Alivira operates through Alivira Animal Health Limited.

The legal entities of Alivira currently have 6 directors, including Saurav Bhala, Srinivas Vasireddy, Vijayalakshmi and others.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available